J 2021

Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study

BÚŘIL, Jiří, Petra BÚŘILOVÁ, Andrea POKORNÁ, Ingrid KOVACOVA, Marek BALÁŽ et. al.

Základní údaje

Originální název

Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study

Autoři

BÚŘIL, Jiří (203 Česká republika, garant, domácí), Petra BÚŘILOVÁ (203 Česká republika, domácí), Andrea POKORNÁ (203 Česká republika, domácí), Ingrid KOVACOVA (203 Česká republika) a Marek BALÁŽ (703 Slovensko, domácí)

Vydání

Plos one, San Francisco, Public Library of Science, 2021, 1932-6203

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.752

Kód RIV

RIV/00216224:14110/21:00121355

Organizační jednotka

Lékařská fakulta

DOI

UT WoS

000616736200026

Klíčová slova anglicky

Parkinson's disease; atypical Parkinson's syndromes

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 7. 4. 2021 10:28, Mgr. Tereza Miškechová

Anotace

V originále

Background Parkinson's disease is a progressive neurodegenerative disease which causes health problem that affects more patients in the past few years. To be able to offer appropriate care, epidemiological analyses are crucial at the national level and its comparison with the international situation. Aim The demographic description of reported patients with parkinsonism (including Parkinson's disease and atypical parkinsonian syndromes) according to the International Classification of Diseases (ICD-10) from the national health registries. Methods Retrospective analysis of data available from the National Health Information System-NHIS and the National Registry of Reimbursed Health Services (NRRHS). Analyzed epidemiological data are intending to determine the regional and specific prevalence of Parkinsonism in the Czech Republic. The International Classification of Diseases diagnoses (ICD-10) of G20 (Parkinson's disease-PD) and G23.1, G23.2, G23.3 (other degenerative disorders of basal ganglia), and G31.8 (another degenerative disease of basal ganglia) from the period of 2012 to 2018 were included into the analysis. Results We identified 78 453 unique patients from national registries in the period 2012 to 2018. Diagnoses of G20, G23.1, G23.2, and G31.8 were registered as the principal diagnoses in 76.6% of all individual patients. Conclusion We have found a growing number of patients coded with ICD-10 of dg. G20, G23.1, G23.2, G23.3, or G31.8 (N = 27 891 in 2012, and N = 30 612 in 2018). We have proven regional differences in the prevalence of Parkinson ' s diagnoses. Therefore we assume most likely also differences in the care of patients with PD based on the availability of specialty care centers.